Beiyun Chen

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

Peter A Kaufman, Lyndsay N Harris, James N Ingle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.

J. Teruya-Feldstein, R. Chaganti, C. Hedvat, 2002, Human pathology.

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

Krishna R. Kalari, Jeanette E Eckel-Passow, Krishna R Kalari, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.

James N Ingle, Matthew P Goetz, Edith A Perez, 2010, Human pathology.

Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique.

A. Clayton, A. Nassar, R. Ketterling, 2012, American journal of clinical pathology.

Update on Immunohistochemical Analysis in Breast Lesions.

Ping Tang, P. Tang, Yan Peng, 2017, Archives of pathology & laboratory medicine.